Sero-prevalence of mumps antibodies in subpopulations subsequently affected: By a large scale mumps epidemic in Israel

Vaccine

Volumn 29, Issue 22, 2011, Pages 3878-3882

  Muhsen, Khitam ^a   Shohat, Tamy ^a,b   Aboudy, Yair ^b   Mendelson, Ella ^a,b   Algor, Nurit ^c   Anis, Emilia ^b,d   Cohen, Dani ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c Sha'ari Zedek Medical Center   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Epidemics; Mumps; Sero epidemiology; Serum IgG antibodies

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MUMPS VACCINE; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; MUMPS; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; BLOOD; EPIDEMIC; EPIDEMIOLOGY; IMMUNOLOGY; INFANT; RISK FACTOR;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; ISRAEL; MALE; MUMPS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 80051744378     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.047     Document Type: Article

References (30)

1. Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000;284:2643-7.
2. Peltola H, Jokinen S, Paunio M, Hovi T, Davidkin I. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infect Dis 2008;8:796-803.
3. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009;27: 6186-95.
4. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358:1580-9.
5. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999;77:3-14.
6. Centers for disease control and prevention. Mumpsepidemic-United kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep 2006;55:173-5.
7. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005;330:1132-5.
8. Health Protection Agency Laboratory confirmed number of mumps cases in England and Wales: update to end-November 2010. Available from: http://www.hpa.org.uk/hpr/archives/2010/news0210.htm#mmps; 2009 [accessed 17.08.10].
9. Centers for Disease Control Prevention, Update: multistate outbreak of mumps-United States, January 1-May 2. MMWR Morb Mortal Wkly Rep 2006;55:559-63.
10. Centers for Disease Control Prevention, Update: mumps outbreak-New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010;59:125-9.
11. Boxall N, Kubinyiova M, Prikazsky V, Benes C, Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005-2006. Euro Surveill 2008;13(16).
12. Castilla J, García Cenoz M, Barricarte A, Irisarri F, Nunez-Cordoba JM. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveill. 2007;12(7):pii=3139. Available online: http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=3139.
13. Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Australia 2009;191:398-401.
14. Sartorius B, Penttinen P, Nilsson J, et al. An outbreak of mumps in Sweden February-April 2004. Euro Surveill 2005;10:191-3.
15. Schmid D, Pichler AM, Wallenko H, Holzmann H, Popow-Kraupp T, Allerberger F. Mumps outbreak affecting adolescents and young adults in Austria, 2006: update. Euro Surveill. 2006;11(27):pii=2994. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2994.
16. Schwarz NG, Bernard H, Melnic A, et al. Mumps outbreak in the Republic of Moldova, 2007-2008. Pediatr Infect Dis J 2010;29:703-6.
17. Muhsen K, Aboudy Y, Mendelson E, Green MS, Cohen D. Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease. Epidemiol Infect 2008;136:688-93.
18. Department of Epidemiology, Israel Minstry of Health. Weekly reports. Minstry of Health. Available from: http://www.health.gov.il/ pages/default.asp?maincat=9&catId=40&PageId=2648; 2010 [accessed 17.08.10].
19. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill 2009;14(50).
20. Gurovich N, Cohen-Kastro E. Ultra-orthodox Jews geographic distribution and demographic social and economic characteristics of the ultra-orthodox Jewish population in Israel 1996-2001. Central Bureau of Statistics; 2004.
21. Central Bureau of Statistics. Characteristics of the ultra orthodox Jewish population. Available from: http://www.cbs.gov.il/ www/publications/quality religion.xls; 2010. [accessed September, 2010].
22. Tischer A, Andrews N, Kafatos G, et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect 2007;135: 787-97.
23. Fine P, Mulholland K. Community immunity. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. SAUNDRES Elsevier Inc.; 2008. p. 1577-82.
24. Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations: what makes good even better? Hum Vaccin 2009;5:494-6.
25. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008;47:1458-67.
26. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008;26:3601-7.
27. Dominguez A, Torner N, Castilla J, et al. Mumps vaccine effectiveness in highly immunized populations. Vaccine 2010;28:3567-70.
28. Nojd J, Tecle T, Samuelsson A, Orvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001;19:1727-31.
29. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008;46:1172-80.
30. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year followup. J Infect Dis 2008;197:950-6.